↓ Skip to main content

PLOS

No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients

Overview of attention for article published in PLOS ONE, May 2012
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
5 X users
facebook
2 Facebook pages

Readers on

mendeley
23 Mendeley
Title
No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients
Published in
PLOS ONE, May 2012
DOI 10.1371/journal.pone.0036073
Pubmed ID
Authors

Ramon Mendoza, Robert H. Silverman, Eric A. Klein, A. Dusty Miller

Abstract

XMRV (xenotropic murine leukemia virus-related virus) was initially discovered in association with prostate cancer and later with chronic fatigue syndrome (CFS). Its association with CFS is now largely discredited, and current results support a laboratory origin for XMRV with no reproducible evidence for infection of humans. However, some results indicating the presence of XMRV in prostate cancer are difficult to attribute to sample contamination. Here we have sought biological evidence that might confirm the presence of XMRV in prostate cancer samples previously having tested positive.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 4%
Denmark 1 4%
Unknown 21 91%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 17%
Student > Master 3 13%
Professor 2 9%
Other 2 9%
Student > Bachelor 2 9%
Other 7 30%
Unknown 3 13%
Readers by discipline Count As %
Medicine and Dentistry 7 30%
Agricultural and Biological Sciences 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Unspecified 1 4%
Mathematics 1 4%
Other 4 17%
Unknown 5 22%